Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 8Leukemia, Myelomonocytic, Chronic 7Leukemia 7Leukemia, Myeloid, Acute 6Anemia, Refractory, with Excess of Blasts 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Polycythemia Vera 4Blast Crisis 4Thrombocythemia, Essential 3Primary Myelofibrosis 3Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Promyelocytic, Acute 2Leukemia, Myelomonocytic, Acute 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Anemia, Refractory 2Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large-Cell, Anaplastic 1

Interventions

eltrombopag 3Platelet Transfusion 2Busulfan 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2siltuximab 1oprelvekin 1fludarabine phosphate 1fludarabine 1Vitamin E 1Tranexamic Acid 1Topotecan 1Stem Cell Transplantation 1Peripheral Blood Stem Cell Transplantation 1Observation 1Microarray Analysis 1Isotretinoin 1Interleukin-11 1Hematopoietic Stem Cell Transplantation 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Etoposide 1Decitabine 1DNA Methylation 1Cytogenetic Analysis 1Cytarabine 1Cyclophosphamide 1Biopsy 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombocytopenia × Topotecan × Myeloid × Clear all
NCT00003619 2013-06-26

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic Leukemia

National Cancer Institute (NCI)

Phase 1/2 Completed
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Blast Crisis, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocytopenia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡